Ever wondered what sets the leading Dr. Reddy’s manufacturing plants in India apart? With so many factories cranking out life-saving medicines, choosing the right supplier can feel overwhelming. Picking the best factory isn’t just about quality—it means confidence in reliable delivery, cutting-edge technology, and global standards. The right partner safeguards both your reputation and your bottom line. Curious which Dr. Reddy’s plants truly rise above the rest? Dive in and discover which manufacturers deserve your trust!

Related Video

Dr. Reddy’s Laboratories – Good Health Can’t Wait

Dr Reddy’s Drugs: Where Are They Really Made?

Product Details:
Dr Reddy’s produces a wide range of pharmaceutical products, including generic medicines (tablets, capsules, injectables, topicals), bulk drug ingredients (APIs), and advanced specialty drugs for diseases such as cancer and HIV. Products are manufactured both in India (major hubs like Hyderabad, Visakhapatnam, Baddi, Srikakulam) and internationally (US, UK, Russia), complying with regulatory standards such as US FDA, EMA, and WHO.

Technical Parameters:
– Over 20 global manufacturing sites, including 10+ major plants in India
– Plants cleared by regulators like US FDA, EMA (Europe), WHO, and Indian CDSCO
– Capability for high-complexity products (injectables, oncology drugs, HIV
– US FDA-approved plants for exports and local manufacturing in global markets

Application Scenarios:
– Hospitals, clinics, and pharmacies needing quality-assured generic and
– Patients requiring affordable medications for common and advanced conditions
– International markets requiring local manufacture to meet jurisdiction-specific
– Supply to government and private healthcare facilities across more than 60

Pros:
– Wide global presence and strong regulatory approvals ensuring product
– Advanced R&D investment enables both affordable generics and innovative drugs
– Local manufacturing in key markets (US, UK, Russia) ensures faster supply and
– Comprehensive manufacturing from APIs to finished drugs, improving supply chain

Cons:
– Packaging may only indicate headquarters or office location, not actual
– Variability in manufacturing locations can cause inconsistency in perceived
– Need to check manufacturing license numbers on packaging for true source,

Discovering the Manufacturing Locations of Dr. Reddy’s Pharmaceuticals

Product Details:
Dr. Reddy’s Laboratories manufactures a wide range of pharmaceutical products, including generic medicines and active pharmaceutical ingredients (APIs), as well as finished formulations like tablets, capsules, injectables, and specialized medications across various therapeutic categories such as pain management and oncology.

Technical Parameters:
– Facilities feature vertical integration, from raw material synthesis to final
– Advanced automation and digitalization in manufacturing processes for increased
– State-of-the-art plants specializing in both large-scale formulations and
– Stringent quality standards and regulatory compliance adhered to across all

Application Scenarios:
– Supplying essential and specialized medications to meet medical needs in
– Production of generic drugs to offer cost-effective alternatives for various
– Partnerships with healthcare providers for large-scale medicine distribution
– Research and development for innovative drug delivery systems and expanding

Pros:
– Wide range of high-quality, affordable, and accessible medications across
– Strong focus on innovation, research, and continuous improvement of drug
– Global presence with facilities optimized for efficient supply chain management
– Commitment to strict quality standards and regulatory compliance

Cons:
– Complexity in managing highly diversified, multi-location manufacturing
– Potential challenges in consistently maintaining standards and regulatory

Where Are Dr Reddy’s Drugs Manufactured? Inside India’s Pharma Powerhouse

Product Details:
Dr. Reddy’s manufactures a wide range of pharmaceuticals including generic medicines, active pharmaceutical ingredients (APIs), biosimilars, and over-the-counter (OTC) products.

Technical Parameters:
– Products are manufactured in US FDA, UK MHRA, and WHO-GMP certified facilities.
– Manufacturing facilities are located in multiple Indian cities including
– Quality control labs at manufacturing units for stringent safety and efficacy

Application Scenarios:
– Supplying generic medicines to domestic and international markets.
– Production of APIs for use in various pharmaceutical formulations.
– Manufacturing biosimilars for therapeutic use in critical diseases.
– OTC medicines for general health and wellness.

Pros:
– High international regulatory compliance, ensuring global acceptance.
– Vertically integrated operations from APIs to finished dosage forms.
– Diverse manufacturing locations for risk mitigation and efficiency.
– Strong focus on quality control and regulatory certifications.

Cons:
– Susceptible to external regulatory inspections and international compliance
– Dependence on multiple locations may complicate logistics and increase

FDA slams Dr. Reddy’s plants in India with a pair of Form 483s

Cons:
– FDA cited manufacturing deficiencies at Dr. Reddy’s Indian plants.
– Issues included lack of proper controls and failure to maintain facilities to

Dr. Reddy’s Laboratories in India – ICH GCP

Dr Reddy’s gets FDA warning letter for three drug plants

Product Details:
Dr. Reddy’s Laboratories manufactures pharmaceutical products at its drug manufacturing plants in India.

Application Scenarios:
– Production of drugs for export to the United States
– Manufacturing of generic pharmaceutical medications

Cons:
– Received an FDA warning letter regarding poor quality control and manufacturing
– US FDA identified violations at three manufacturing plants
– Potential suspension or delay in product approvals for the US market

Dr. Reddy’s sells plants in India and Tennessee

Product Details:
Dr. Reddy’s manufactures active pharmaceutical ingredients (APIs) and pharmaceutical chemical intermediates at its plants in India.

Application Scenarios:
– Production of pharmaceutical products
– Supplying APIs to global pharmaceutical companies

Pros:
– Well-established manufacturing facilities
– Experience in producing pharmaceutical ingredients

Cons:
– Asset divestiture may indicate shifting business priorities or potential
– Uncertainty for continuity of supply due to plant sale

Dr Reddy’s Laboratories: Dr Reddy’s Faces USFDA Scrutiny with 2 …

Product Details:
Active Pharmaceutical Ingredients (APIs) manufactured at Dr Reddy’s Telangana facility. The plant recently underwent USFDA inspection and received 2 observations.

Application Scenarios:
– Pharmaceutical manufacturing using APIs produced at Telangana plant
– Supplying APIs to generic and branded pharmaceutical market

Pros:
– Production facilities are regularly inspected which may lead to improved
– APIs supply supports pharmaceutical formulation manufacturers

Cons:
– Recent USFDA scrutiny resulting in 2 observations may signal compliance or
– Potential regulatory hurdles could delay production or exports

Global Locations – Dr. Reddy’s Laboratories

Product Details:
Dr. Reddy’s Laboratories is a multinational pharmaceutical company focused on manufacturing Active Pharmaceutical Ingredients (APIs), formulations, and providing pharmaceutical services globally. The company operates manufacturing and R&D facilities across multiple countries including the USA, Mexico, United Kingdom, China, India, and others.

Technical Parameters:
– Specialized manufacturing facilities for APIs and pharmaceutical formulations
– Dedicated R&D locations in New Jersey (USA), Cambridge (UK), and multiple sites
– Plants and facilities equipped for both API and finished dosage form production

Application Scenarios:
– Supplying active pharmaceutical ingredients and finished medicines to health
– Contract manufacturing and custom pharmaceutical development for third-party
– Enhancing generic drug access and affordability across regulated and emerging

Pros:
– Global manufacturing and supply chain coverage, enabling service to multiple
– Diverse production capabilities, including both API and formulations, allowing
– Multiple R&D centers supporting innovation, formulation development, and

Cons:
– Operations reliant on regulatory compliance across numerous countries,
– No direct technical product specifications (e.g., drug types, dosage strengths,

Comparison Table

Frequently Asked Questions (FAQs)

How can I find the locations of Dr. Reddy’s manufacturing plants in India?
You can find a list of Dr. Reddy’s manufacturing plant locations on the official Dr. Reddy’s website, under their “Locations” or “Manufacturing Facilities” sections. Additionally, reliable business directories and industry reports may detail their plant locations across cities such as Hyderabad, Vishakhapatnam, and Baddi.

How do I contact Dr. Reddy’s to inquire about becoming a supplier or partner?
Visit Dr. Reddy’s official website and navigate to the “Contact Us” or “Business Enquiries” page. Here you’ll find specific email addresses and forms for supplier queries and business partnerships. Reaching out through their official channels ensures that your inquiry reaches the relevant department.

What criteria should I consider when choosing a Dr. Reddy’s manufacturing facility?
Consider the facility’s regulatory approvals (like USFDA or WHO-GMP), production capacity, location convenience for logistics, and specialization in particular product types. It’s also wise to review their track record in compliance and quality assurance practices.

How can I verify the quality standards of Dr. Reddy’s manufacturing plants?
Dr. Reddy’s plants are certified by regulatory bodies such as USFDA, EMA, and WHO-GMP. You can request copies of relevant certifications and inspection reports directly from their business development team to ensure the facility meets your required standards.

Can I visit a Dr. Reddy’s manufacturing facility before making a decision?
Facility visits are sometimes possible, especially for potential business partners or large clients. It’s best to arrange a visit through their official corporate channels, explaining your business interest and proposed partnership to schedule a tour, subject to their approval and policies.